Glucose Metabolism in Patients With Schizophrenia Treated With Atypical Antipsychotic Agents

Abstract

Both nonobese clozapine- and olanzapine-treated groups displayed significant insulin resistance and impairment of glucose effectiveness compared with risperidone-treated subjects. Patients taking clozapine and olanzapine must be examined for insulin resistance and its consequences.